Test Price
2,800 AED✅ Home Collection Available
ST6GAL2 Gene Beta-Galactoside Alpha-2,6-Sialyltransferase 2 Deficiency Genetic Test in UAE
Executive Summary & Core Metrics
Clinical Confidence: 99.9% diagnostic sensitivity via ISO 9001:2015 certified next-generation sequencing (NGS) processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post-test clinical guidance in result interpretation included.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ST6GAL2 Gene NGS Test is a high-resolution genetic analysis that detects pathogenic variants in the ST6GAL2 gene linked to Beta-Galactoside Alpha-2,6-Sialyltransferase 2 deficiency, a rare congenital disorder of glycosylation (CDG). This test provides definitive molecular diagnosis for metabolic disorders, aiding clinical management, family planning, and precision wellness strategies.
| Parameter | Our Test (DHA-Approved) | Closest Alternative |
|---|---|---|
| Precision | 99.9% analytical sensitivity with full gene coverage via NGS | Limited to single-exon deletion/duplication assays |
| Methodology | Next Generation Sequencing (NGS) with advanced bioinformatics | Sanger sequencing of selected hotspots |
| Turnaround Time | 3 to 4 Weeks (expedited reporting available) | 6–8 Weeks with potential re-extraction delays |
Physician Insight & Safety Protocols
“Molecular confirmation of ST6GAL2 deficiency via NGS provides clarity for families navigating a complex metabolic disorder. However, genotype-phenotype correlation remains essential; a negative result does not exclude other glycosylation pathway defects. Always integrate biochemical data and family pedigree before finalising clinical decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Important Medication Advisory
Do not discontinue any prescribed medication, dietary supplement, or metabolic therapy without consulting your doctor. Abrupt changes can destabilise metabolic control and lead to clinical decompensation.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Unstable acute illness, febrile state >38.5 °C, or recent blood transfusion (within 2 weeks) may delay collection.
- Exclusion: Known bleeding disorder or therapeutic anticoagulation without physician clearance; contact our team for alternative collection methods.
- Emergency Red Flag: Sudden onset of severe metabolic acidosis, intractable seizures, or hypoglycemia unresponsive to oral intake — seek emergency care immediately; this test is not intended for acute crisis diagnosis.
- Minor Consent: For patients under 18 years, valid guardian consent is mandatory. Home collection for minors requires a guardian to be present throughout the procedure.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the ST6GAL2 NGS test?
This test definitively identifies pathogenic mutations in the ST6GAL2 gene, enabling accurate diagnosis of a congenital disorder of glycosylation that can cause developmental delay, coagulopathy, and endocrine abnormalities. Results guide metabolic management and family planning decisions.
2. How is the sample collected and is home service available in the UAE?
A certified phlebotomist collects a small blood sample (whole blood, extracted DNA, or a one-drop blood on FTA card) during a scheduled home visit within our 8 AM–11 PM slot, under cold-chain conditions. Home collection is available across all seven emirates.
3. Do I need genetic counselling before this test?
Yes, pre-test genetic counselling is strongly recommended to review family history, draw a pedigree chart, and explain possible outcomes, inheritance pattern, and implications for at-risk relatives. Our genetics team can facilitate this consultation.
4. How long does it take to receive results?
The standard turnaround time is 3 to 4 weeks from sample receipt. Expedited reporting is available upon request; please speak to our customer service team for details.
5. Will my insurance cover the cost of this genetic test?
Coverage varies by insurer and policy. We offer direct billing verification via WhatsApp at +971 54 548 8731. Please contact us with your policy details to check eligibility before scheduling.
UAE Regulatory & Data Privacy Adherence
All genetic testing and data handling at DNA Labs UAE are conducted in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Genetic data is anonymised and stored on encrypted servers within UAE jurisdiction. DHA Facility License Number: 1143.
Clinical & Logistical Metadata
| Test Name | ST6GAL2 Gene Beta-Galactoside Alpha-2,6-Sialyltransferase 2 Deficiency Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks (expedited reporting available) |
| Sample Type / Matrix | Whole blood (peripheral), extracted DNA, or FTA card spot |
| Methodology Used | Next Generation Sequencing (NGS) with full gene coverage and bioinformatics analysis |
| ICD-10-CM Code | E77.8 |
| LOINC Code | 94473-4 |
| DHA Facility License & Laboratory Address | DNA Labs UAE | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians